CLASS II ONGOING Device recall · Reported 11 Feb 2026 · FDA Enforcement Report
Lumipulse G ¿-Amyloid 1-42-N Plasma Calibrators recalled
Fujirebio Diagnostics is recalling Lumipulse G ¿-Amyloid 1-42-N Plasma Calibrators, distributed nationwide in the US. The recall was initiated on 11 Dec 2025 and the FDA has classified it as Class II.
Check your package
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
Recall details
- Recall number
- Z-1306-2026
- FDA event ID
- 98232
- Recalling firm
- Fujirebio Diagnostics, Malvern, PA
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- 11 Dec 2025
- FDA classified
- 5 Feb 2026
- Reported
- 11 Feb 2026
- Type
- Voluntary: Firm initiated
- Customers notified by
- Letter
- Reason category
- Labeling Errors
- Device type
- Medical Software
Timeline
| 11 Dec 2025 | Recall initiated by company | |
| 5 Feb 2026 | Classified by FDA | +56 days |
| 11 Feb 2026 | Published in enforcement report | +6 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
Product as listed by the FDA
Product Name: Lumipulse G ¿-Amyloid 1-42-N Plasma Calibrators Model/Catalog Number: 235454 Software Version: Not Applicable Product Description: Lumipulse G ¿-Amyloid 1-42-N Plasma Calibrators: The ¿-Amyloid 1-42 plasma concentration of a specimen is automatically calculated from the calibration curve, which is automatically calculated from calibration data. The result of the calculation is reported in pg/mL. Lumipulse G ¿-Amyloid 1-42-N Plasma Calibrators: Liquid (Frozen), 1 ¿ 1.5 mL (4 Concentrations) CAL 1 0 pg/mL ¿-Amyloid 1-42-N Plasma Calibrator CAL 2 30 pg/mL ¿-Amyloid 1-42-N Plasma Calibrator CAL 3 100 pg/mL ¿-Amyloid 1-42-N Plasma Calibrator CAL 4 1000 pg/mL ¿-Amyloid 1-42-N Plasma Calibrator Contains Tris buffer with protein (bovine) and chemical stabilizers. Preservative: 0.1% ProClin 950. Component: Yes. Lumipulse G pTau217/B-Amyloid 1-42 Plasma Ratio
Where it was distributed
US Nationwide distribution in the states of Arizona, California, Florida, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Minnesota, New Jersey, Pennsylvania, Texas, Washington.
Nationwide ArizonaCaliforniaFloridaIndianaKansasKentuckyMassachusettsMarylandMinnesotaNew JerseyPennsylvaniaTexasWashington
Questions about this recall
Why was it recalled?
Customers may experience inaccurate test results by observing a higher frequency of classification in the indeterminate and positive zone and/or low specificity when compared back to FDA-cleared CSF ratio/PET imaging, due to falsely elevated positive ratio or falsely elevated indeterminate ratio results causing an incorrect classification of a patient as having amyloid pathology associated with Alzheimer s disease (positive result) and/or requiring more clinical testing of that patient (indeterminate result).
Which lots are affected?
Model/Catalog Number: 235454; UDI-DI: 04987270235454; Lot Numbers: D8C6022U, D8C6044U;
Where was it sold?
US Nationwide distribution in the states of Arizona, California, Florida, Indiana, Kansas, Kentucky, Maryland, Massachusetts, Minnesota, New Jersey, Pennsylvania, Texas, Washington.
What should I do if I have it?
Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.
What does Class II mean?
Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
Other products in this recall event
6 other products · FDA event 98232This product is part of a recall event; the main page for the event is Lumipulse pTau 217 Plasma Controls recalled by Fujirebio Diagnostics.
More recalls from Fujirebio Diagnostics
All 7| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS II | Lumipulse G pTau 217 Plasma Immunoreaction Cartridges recalled | Fujirebio Diagnostics | Labeling Errors | Nationwide |
| Device | CLASS II | Lumipulse G ¿-Amyloid 1-42-N Plasma Immunoreaction Cartridges recalled | Fujirebio Diagnostics | Labeling Errors | Nationwide |
| Device | CLASS II | Lumipulse ¿-Amyloid Plasma Controls recalled by Fujirebio Diagnostics | Fujirebio Diagnostics | Labeling Errors | Nationwide |
| Device | CLASS II | Lumipulse G pTau217/B-Amyloid 1-42 Plasma Ratio recalled | Fujirebio Diagnostics | Labeling Errors | Nationwide |
| Device | CLASS II | Lumipulse G pTau 217 Plasma Calibrators recalled | Fujirebio Diagnostics | Labeling Errors | Nationwide |
Other Medical Software recalls
All 932| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Device | CLASS III | Kit: Urinary Clean Catch 20/cs recalled by Medical Action Industries | Medical Action Industries Inc. 306 | Device Malfunction | CA |
| Device | CLASS II | Spectral CT and Spectral CT 7500 RT recalled by Philips Medical Systems | Philips Medical Systems | Device Malfunction | Nationwide |
| Device | CLASS II | SmartPath to dStream for XR and 3.0T recalled by Philips North America | Philips North America | Device Malfunction | Nationwide |
| Device | CLASS II | Upgrade to MR recalled by Philips North America | Philips North America | Device Malfunction | Nationwide |
| Device | CLASS II | Positron Emission Tomography and Computed Tomography System recalled | Shanghai United Imaging Healthcare | Device Malfunction | Nationwide |